By Madhava Setty, M.D. | The Defender | November 9, 2022 Pfizer last week announced what some media outlets called “good news” about its COVID-19 bivalent booster, for which the U.S. Food and Drug Administration (FDA) in August granted Emergency Use Authorization on the basis of testing conducted on eight mice. In a press release, Pfizer summarized the updated […]
Source